Mary K Frohnauer, MD in La Crosse, WI - Internal Medicine

Mary K Frohnauer, MD is a Internal Medicine - Endocrinology, Diabetes & Metabolism physician based in La Crosse, Wisconsin. Mary K Frohnauer is licensed to practice in Wisconsin (license number 41046) and her current practice location is 1836 South Ave, La Crosse, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (608) 775-2021.

NPI number for Mary K Frohnauer is 1013018704 and her current mailing address is 1836 South Ave, La Crosse, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013018704.

Contact Information

	Mary K Frohnauer, MD
	1836 South Ave, La Crosse, WI 54601-5429
	(608) 775-2021
	Not Available

Physician's Profile

Full Name	Mary K Frohnauer
Gender	Female
Speciality	Internal Medicine - Endocrinology, Diabetes & Metabolism
Location	1836 South Ave, La Crosse, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013018704
Provider Enumeration Date: 09/26/2006
Last Update Date: 09/14/2015

Medical Identifiers

Medical identifiers for Mary K Frohnauer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013018704	NPI	-	NPPES
32572300	Medicaid	WI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	41046 (Wisconsin)	Secondary
207RE0101X	Internal Medicine - Endocrinology, Diabetes & Metabolism	41046 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary K Frohnauer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mary K Frohnauer, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300	Mary K Frohnauer, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 775-2021

News Archive

Hemp Health launches CBD wellness supplements

Hemp Health Inc., a pioneer in hemp cannabidiol (CBD) products, today launched their line of CBD wellness supplements. Available in oil, spray and capsule form, Hemp Health's products offer a compelling alternative to medical marijuana. The CBD supplements provide consumers with the therapeutic ingredient in hemp while allowing them to avoid the negative mental and physical effects of marijuana.

U-M researchers reveal key gene that may provide potential target for cancer treatment

One of the mysteries in cancer biology is how one protein, TGF-beta, can both stop cancer from forming and encourage its aggressive growth.

Study suggests novel therapeutic strategy for ALS

In a study published online in Brain on April 1, researchers from Dr. XU Jin's lab at the Institute of Neuroscience of the Chinese Academy of Sciences and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis, suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS.

Approximately six million people in India's Delhi territory at risk of contracting tuberculosis

About six million people in the Indian territory of Delhi, or 40% of the territory's population of 15 million, are at risk of contracting tuberculosis, L.S. Chauhan, deputy director general of India's Ministry of Health and Family Welfare, said recently ahead of the International Union Against TB and Lung Disease's Conference of the South East Asia Region, which begins Monday in New Delhi, IANS/Economic Times reports. The three-day conference will bring together about 500 experts from South Asia and France to discuss the threat of TB and other lung diseases.

Angiochem to highlight oncology program data at 101st American Association for Cancer Research meeting

Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier through LRP targeting, announced today that preclinical data on two of its oncology programs, ANG1005 and ANG1007, for the treatment of brain cancers, as well as data demonstrating the utility of Angiochem's EPiC platform to achieve efficient penetration rates in the brain and in cancer tumor tissue, will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010.

Internal Medicine Doctors in La Crosse, WI

Derek A Hupp, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300
Padmavathi Mali, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300
Emily Catherine Dolan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300
Blake Donald Jordan, DO Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300
Adie D Harbin Iii, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300
Gregory M Knorr, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300

Mary K Frohnauer, MD - Internal Medicine in La Crosse, WI